Ceribell (CBLL) Total Non-Current Liabilities (2023 - 2026)
Ceribell (CBLL) posted Total Non-Current Liabilities of $21.1 million for Q1 2026, down 0.92% on a QoQ basis from $21.3 million in Q4 2025, and up 1.55% year-over-year from $20.8 million in Q1 2025.
Ceribell (CBLL) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Ceribell's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $21.1 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 1.55% year-over-year to $21.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.1 million (up 1.55% YoY) and the FY2025 annual result came in at $21.3 million, changed 0.09% from the prior year.
- Total Non-Current Liabilities was $21.1 million for Q1 2026 at Ceribell, down from $21.3 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $22.5 million in Q3 2024 and bottomed at $2.2 million in Q4 2023.
- A 4-year average of $18.7 million and a median of $20.9 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities jumped 883.26% — and 2025, when it declined 10.04%.
- Ceribell's Total Non-Current Liabilities stood at $2.2 million in 2023, then soared by 883.26% to $21.3 million in 2024, then gained by 0.09% to $21.3 million in 2025, then fell by 0.92% to $21.1 million in 2026.
- Business Quant data shows CBLL's Total Non-Current Liabilities at $21.1 million in Q1 2026, $21.3 million in Q4 2025, and $20.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 21.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.08 Mn |
| Dec 31, 2025 | 21.28 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 20.52 Mn |
| Mar 31, 2025 | 20.76 Mn |
| Dec 31, 2024 | 21.26 Mn |
| Sep 30, 2024 | 22.54 Mn |
| Dec 31, 2023 | 2.16 Mn |